Intermediate doses of low-molecular-weight heparin for the long-term treatment of pregnancy thromboembolism. A systematic review

Thrombosis and Haemostasis

Volumn 111, Issue 3, 2013, Pages 559-561

  Gándara, Esteban ^a,b   Carrier, Marc ^a,b   Rodger, Marc A ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10A INHIBITOR; DALTEPARIN; HEPARIN CALCIUM; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ANTICOAGULATION; DEEP VEIN THROMBOSIS; HUMAN; LETTER; LONG TERM CARE; POSTPARTUM HEMORRHAGE; PREGNANCY ASSOCIATED VENOUS THROMBOEMBOLISM; PREGNANCY DISORDER; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; DRUG DOSAGE CALCULATIONS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; TIME FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84897041112     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-06-0510     Document Type: Letter

References (25)

1. Bates SM, Greer I, Middeldorp S, et al. VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; Suppl: e691S-e736S.
2. Abou-Nassar K, Kovacs MJ, Kahn SR, et al. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial. Thromb Haemost 2007; 98: 163-171.
3. Sephton V, Farquharson RG, Topping J, et al. A Longitudinal Study of Maternal Dose Response to Low Molecular Weight Heparin in Pregnancy. Obstet Gynecol 2003; 101: 1307-1311.
4. Barbour LA, Oja JL, Schultz LK. A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation. Am J Obstet Gynecol 2004; 191: 1024-1029.
5. Arya R. How I manage venous thromboembolism in pregnancy. Br J Haematol 2011; 153: 698-708.
6. Middeldorp S. How I treat pregnancy-related venous thromboembolism. Blood 2011; 118: 5394-5400.
7. Hull RD, Townshend G. Long-term treatment of deep-vein thrombosis with low-molecular-weight heparin: An update of the evidence. Thromb Haemost 2013; 110: 14-22.
8. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic Therapy for VTE Disease Antithrombotic Therapy for VTE Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e419S-e494S.
9. Rodger M. Evidence base for the management of venous thromboembolism in pregnancy. Hematology Am Soc Hematol Educ Program 2010; 173-180.
10. Bauersachs RM. Treatment of venous thromboembolism during pregnancy. Thromb Res 2009; 123: S45-S50.
11. Miller S, Lester F, Hensleigh P. CEU: Prevention and Treatment of Postpartum Hemorrhage: New Advances for Low-Resource Settings. J Midwifery Womens Health 2004; 49: 283-292.
12. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2009. Report. Available at http://www.ohri.ca/programs/ clinical_epidemiology/oxford.asp.
13. Laird NM, Mosteller F. Some statistical methods for combining experimental results. Int J Technol Assess Health Care; 6: 5-30.
14. Barillari G, Springolo F, Daminiato R, et al. Safety and efficacy of nadroparin for the management of venous thromboembolism or thrombophilia in pregnancy. J Thromb Haemost 2007; 5: Abstract P-S-623.
15. Daskalakis G, Antsaklis A, Papageorgiou I, et al. Thrombosis prophylaxis after treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 1997; 74: 165-167.
16. Lyall H, Myers B. Incidence and management of 82 cases of pregnancy-associated venous thromboembolism occurring at a single centre--comparison with Voke et al. Br J Haematol 2008; 142: 309-311.
17. Mitic G, Povazan L, Lucic AM. Treatment of pregnancy related venous thromboembolism. Med Pregl 2009; 62: 346-351.
18. Smith MP, Norris LA, Steer PJ, et al. Tinzaparin sodium for thrombosis treatment and prevention during pregnancy. Am J Obstet Gynecol 2004; 190: 495-501.
19. Ulander VM, Stenqvist P, Kaaja R. Treatment of deep venous thrombosis with low-molecularweight heparin during pregnancy. Thrombosis Res 2002; 106: 13-17.
20. Rodie VA, Thomson AJ, Stewart FM, et al. Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series. Br J Obstet Gynecol 2002; 109: 1020-1024.
21. Voke J, Keidan J, Pavord S, et al. The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey. Br J Haematol 2007; 139: 545-558.
22. Knight M, UKOSS. Antenatal pulmonary embolism: risk factors, management and outcomes. Br J Obstet Gynecol 2008; 115: 453-461.
23. Iorio A, Guercini F, Pini M. Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants. J Thromb Haemost 2003; 1: 1906-1913.
24. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005; 106: 401-407.
25. Romualdi E, Dentali F, Rancan E, et al. Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature. J Thromb Haemost 2013; 11: 270-281.